67 results
Keyword Phentermine Remove keyword
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1-3 October 2012
PRAC, Last updated: 05/10/2012 -
List item
Press release: Pharmacovigilance Risk Assessment Committee (PRAC) elects chair and vice-chair
PRAC, Last updated: 07/09/2012 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 February 2013
European Medicines Agency, London, UK, from 04/02/2013 to 07/02/2013, Last updated: 02/06/2012 -
List item
News: European Medicines Agency publishes list of human medicines under evaluation
Last updated: 01/03/2012Antineoplastic medicines Phentermine/topiramate Antiobesity medicines Pixantrone … -
List item
Medicines for human use under evaluation 2014–2012
Last updated: 02/06/2021 -
List item
Paediatric Committee (PDCO): 8-10 September 2010
European Medicines Agency, London, UK, from 08/09/2010 to 10/09/2010, Last updated: 16/02/2010pneumology – allergology; Phentermine/topiramate, from Vivus BV, in the therapeutic … -
List item
News: 2012 annual report on EudraVigilance published
Last updated: 26/07/2013 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 February 2023
European Medicines Agency, Amsterdam, the Netherlands, from 06/02/2023 to 09/02/2023, Last updated: 18/08/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6 - 9 February 2023
PRAC, Last updated: 10/02/2023 -
List item
PRAC: Committee agendas, minutes and meeting highlights report archive 2012-2013
Last updated: 01/01/2015 -
List item
Periodic safety update reports (PSURs)
Last updated: 27/07/2022 -
List item
Reinforcing communication with patients and healthcare professionals
Belgrade, Serbia, 23/06/2014, Last updated: 08/07/2014 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 07/06/2021 to 10/06/2021, Last updated: 07/06/2021 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 27/03/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 13/03/2023 to 16/03/2023, Last updated: 18/08/2021Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023 (new)
PRAC, Last updated: 17/03/2023Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
Press release: Extraordinary meeting to finalise review of Anorectic Agents
Last updated: 09/09/1999substances: - amfepramone - phentermine - clobenzorex, fenproporex … -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 23/01/2023 to 26/01/2023, Last updated: 29/11/2022 -
List item
Press release: European Medicines Agency publishes 2012 annual report
Last updated: 16/04/2013 -
List item
Press release: Committee for Proprietary Medicinal Products (CPMP) 32nd plenary meeting
Last updated: 20/11/1997initiated by Belgium for phentermine and amphepramone containing … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022
PRAC, Last updated: 02/12/2022Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023
PRAC, Last updated: 13/01/2023Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 09/01/2023 to 12/01/2023, Last updated: 18/08/2021Topiramate (NAP); topiramate, phentermine (NAP) - EMEA/H/A-31/1520 … -
List item
Pharmacovigilance: Regulatory and procedural guidance
Last updated: 29/04/2016 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2021
Virtual meeting, from 11/01/2021 to 14/01/2021, Last updated: 27/02/2018